DrugPatentWatch Database Preview

TERBUTALINE SULFATE Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Terbutaline Sulfate patents expire, and when can generic versions of Terbutaline Sulfate launch?

Terbutaline Sulfate is a drug marketed by Akorn, Athenex Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Teva Pharms Usa, United Biomedcl, Impax Labs, and Lannett Co Inc. and is included in eight NDAs.

The generic ingredient in TERBUTALINE SULFATE is terbutaline sulfate. There are seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Summary for TERBUTALINE SULFATE

US Patents:	0
Applicants:	8
NDAs:	8
Suppliers / Packagers:	15
Bulk Api Vendors:	81
Clinical Trials:	2
Patent Applications:	2,861
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for TERBUTALINE SULFATE
DailyMed Link:	TERBUTALINE SULFATE at DailyMed

Medical Subject Heading (MeSH) Categories for TERBUTALINE SULFATE

Adrenergic beta-2 Receptor Agonists

Bronchodilator Agents

Sympathomimetics

Tocolytic Agents

US Patents and Regulatory Information for TERBUTALINE SULFATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	TERBUTALINE SULFATE	terbutaline sulfate	INJECTABLE;INJECTION	078151-001	Jan 7, 2008	AP	RX	No	No
Impax Labs	TERBUTALINE SULFATE	terbutaline sulfate	TABLET;ORAL	075877-001	Jun 26, 2001	AB	RX	No	No
Hikma Farmaceutica	TERBUTALINE SULFATE	terbutaline sulfate	INJECTABLE;INJECTION	078630-001	May 20, 2009	AP	RX	No	No
Impax Labs	TERBUTALINE SULFATE	terbutaline sulfate	TABLET;ORAL	075877-002	Jun 26, 2001	AB	RX	No	No

  Purchase this report

see a sample report or, see our see our flat-rate plans

  Purchase this report

see a sample report or, see our see our flat-rate plans